Aarkstore Enterprise---mannkind Corporation (mnkd) - Financial And Strategic Analysis Review

Share:    

MannKind Corporation (MannKind) is a developmental stage biopharmaceutical company

engaged in the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The companys product pipeline includes AFRESA, the Technosphere Insulin System used for the treatment of diabetes; MKC1106-PP, which is in Phase I clinical trial, intended for the treatment of various solid-tumor cancers and melanoma; and MKC1106-MT, which is in phase 1/2 clinical trial for advanced melanoma. The company has its operation spread across the US, Europe and Latin America. MannKind is headquartered in California, the US.

MannKind Corporation Key Recent Developments

Aug 23, 2010 MannKind Corporation To Supply AFREZZA To Juvenile Diabetes Research Foundation For Artificial Pancreas Project

Aug 02, 2010 MannKind Reports Net Loss Of $42.2 Million For Q2 2010

Mar 29, 2010 MannKind Achieves All Milestones Of Research Agreement With MMRF To Develop New Therapy

Mar 29, 2010 MannKind, MMRF Achieve All Milestones To Develop New Multiple Myeloma Therapy

Feb 24, 2010 MannKind Appoints James S. Shannon To Its Board

This comprehensive SWOT profile of MannKind Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the

For more information please contact :

http://www.aarkstore.com/reports/MannKind-Corporation-MNKD-Financial-and-Strategic-Analysis-Review-62805.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise---osteotech, Inc. (oste) - Financial And Strategic Analysis Review Aarkstore Enterprise---cytocore, Inc. (cyoe) - Financial And Strategic Analysis Review Aarkstore Enterprise---immucor, Inc. (blud) - Financial And Strategic Analysis Review Aarkstore Enterprise---nuvasive, Inc. (nuva) - Financial And Strategic Analysis Review Aarkstore Enterprise---quidel Corporation (qdel) - Financial And Strategic Analysis Review Property In Durbanville: 6 Mistakes When Trading Up #6 Option Trading For Begginers Driver Finder Pro Rapidshare Appliances To The Countryside: An Important Strategic Choice The Heart of Strategic Planning - It's Crucial For Your Success What Is The Foreign Trading Index Cycle For Trading Systems Aarkstore Enterprise -South Indian Bank Ltd. (532218) - Financial and Strategic Analysis Review